Deardorf Caren insider trades
Deardorf Caren has filed 16 Form 4s with the SEC that we hold, for Crinetics Pharmaceuticals, Inc. (CRNX) (Director) and Dianthus Therapeutics, Inc. /DE/ (MGTA) (Chief Commercial Officer). Across all of them we count 0 purchases worth $0 and 1 sale worth $42.0K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 6,238 shares of Dianthus Therapeutics, Inc. /DE/ worth $42.0K, dated 2021-09-16. The first filing on our record is dated 2021-07-08 and the latest 2026-09-01.
Crinetics Pharmaceuticals, Inc. (CRNX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Dianthus Therapeutics, Inc. /DE/ (MGTA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-16 | S, sale reported on Form 4 | 6,238 | $42.0K | 2021-09-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1871152) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms